Clinical Trial Update: Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical study evaluates a combined EphA2-targeted CAR-DC and CAR-T cell therapy for non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EphA2-targeted CAR-DC
• EphA2-targeted CAR-T cell therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING